HERA commissioned feasibility study on stockpiling of antimicrobials against AMR published
HERA commissioned an AMR feasibility study on stockpiling, initiated as preparatory actions under the HERA incubator, and covering two key priority areas of HERA: the threat of antimicrobial resistance (AMR) and stockpiling efforts for medical countermeasures.
The study covers and elaborates on:
- Identification of antimicrobials with critical need for undisrupted access
- Analysis of supply chain vulnerabilities for the selected antimicrobials
- Review of existing antimicrobial stockpiling systems at EU and global level
- Identification and assessment of options for stockpiling of antimicrobials at EU level (physical vs virtual alternatives)
The study has been carried out in two phases, each delivering a specific report.
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Bangalore Bioinnovation Centre |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
 |
BD |
AMR NEWS
Your Biweekly Source for Global AMR Insights!
Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.
Don’t miss out on staying ahead in the global AMR movement—subscribe now!